Gastric cancer is one of the common malignant tumors worldwide. Increasing studies have indicated that circular RNAs (circRNAs) play critical roles in the cancer progression and have shown great potential as useful markers and therapeutic targets. However, the precise mechanism and functions of most circRNAs are still unknown in gastric cancer. In the present study, we performed a microarray analysis to detect circRNA expression changes between tumor samples and adjacent nontumor samples. The miRNA expression profiles were obtained from the National Center of Biotechnology Information Gene Expression Omnibus (GEO). The differentially expressed circRNAs and miRNAs were identified through fold change filtering. The interactions between circRNAs and miRNAs were predicted by Arraystar's home-made miRNA target prediction software. After circRNA-related miRNAs and dysregulated miRNAs were intersected, 23 miRNAs were selected. The target mRNAs of miRNAs were predicted by TarBase v7.0. Gene ontology (GO) enrichment analysis and pathway analysis were performed using standard enrichment computational methods for the target mRNAs. The results of pathway analysis showed that p53 signaling pathway and hippo signal pathway were significantly enriched and CCND2 was a cross-talk gene associated with them. Finally, a circRNA-miRNA-mRNA regulation network was constructed based on the gene expression profiles and bioinformatics analysis results to identify hub genes and hsa_circRNA_101504 played a central role in the network.

Gastric cancer ranks the second highest death rate and is the highest morbidity digestive system malignancy in China. Few reports have elucidated the role of long non-coding RNAs (lncRNAs) in the gastric cancer pathogenesis. The present study was aimed to identify aberrantly expressed lncRNAs involved in the progression of gastric cancer and explored their potential functions. A total of 1,297 lncRNAs and 2,037 mRNAs that showed significantly differential expression level between gastric tumor samples and matched adjacent normal tissues were identified in six pairs of samples using microarray assay. To further explore their functions, lncRNAs were classified into different subgroups and mRNAs were clustered into several pathways. The expression level of 4 lncRNAs: UCA1, lincRNA-BBOX1-2, CR594506 and BC015134 were further confirmed in another cohort of 10 gastric patients by real-time PCR assay. A coding-non-coding co-expression network revealed that the four validated lncRNAs were correlated with twenty-six mRNAs which gave clues about the potential roles of these lncRNAs in the process of gastric cancer progression.

long non-coding rnas (lncrnas) play critical roles in the development and progression of cancers. The present study aimed to identify novel lncrnas and associated micrornas (mirnas or mirs) and mrnas in gastric cancer. differentially expressed lncrnas (delncrnas) and differentially expressed mrnas (demrnas) of 6 paired gastric cancer and normal tissues were identified using microarray. The demirnas between gastric cancer and the normal control tissues were identified using mirna-seq data from cancer Genome atlas. common delncrnas from the cancer rna-Seq nexus database and circlncrnanet database were analyzed. a delncrnas-demirnas-demrnas network was constructed by target prediction. Functional enrichment analysis was employed to predict the function of demrnas in the network. The correlation between the expression of delncrnaS and demrnas in the network was analyzed. The expression levels of several genes were validated by reverse transcription-quantitative polymerase chain reaction (rT-qPcr). a total of 1,297 delncrnas, 2,037 demrnas and 171 DEmiRNAs were identified. Among the 4 lncRNAs common to the 3 datasets, prostate androgen-regulated transcript 1 (ParT1) was selected for further analysis. The analysis identified 5 DEmiRNAs and 13 DEmRNAs in the ParT1-mediated cerna network. The demrnas in the cerna network were markedly enriched in cancer-related biological processes (response to hypoxia, positive regulation of angiogenesis and positive regulation of endothelial cell proliferation) and pathways (cGMP-PKG signaling pathway, caMP signaling pathway and proteoglycans in cancer). out of the 13 demrnas, 11 were positively associated with ParT1. The downregulation of ParT1, myosin light chain 9 (MYl9), potassium calcium-activated channel subfamily M alpha 1 (KcnMa1), cholinergic receptor muscarinic 1 (cHrM1), solute carrier family 25 member 4 (SLC25A4) and ATPase na + /K + transporting subunit alpha 2 (aTP1a2) expression levels in gastric cancer was validated by rT-qPcr. on the whole, the current study identified a novel lncrna and associated mirnas and mrnas that are involved in the pathogenesis of gastric cancer that may serve as potential therapeutic targets for the treatment of gastric cancer.

Our everyday technologies could have appeared terrifying to our ancestors: instantaneous disembodied communication, access to knowledge, objects with 'intelligence' that talk to us (and each other). Black boxes and intangible entities are omnipresent in our homes and lives without our necessarily understanding the hidden flows of data, unknown agendas, imaginary clouds, and mysterious rules that govern them. Have humanity's ways of relating to the unknown throughout history gone away, or have they perhaps transmuted into new forms?In an ongoing project, we have inventoried examples, encounters and reflections on contemporary technology, framed through the perspective of the haunted, spectral and otherworldly. In this paper, we excerpt this collection to illustrate the value and opportunity of an unfamiliar, disquieting perspective in helping to frame the frictions, beliefs and myths that are emerging around interactions with everyday technologies. We posit and demonstrate 'spooky technology' as an accessible framework to reflect and respond to our increasingly entangled relationships with technology.

OBJECTIVE: To study: (i) the induction of apoptosis in gastric cancer cells by trichosanthin; and (ii) the relationship between apoptosis and the expression of bcl‐2. METHODS: During in vitro experiments, morphological studies and the terminal deoxynucleotidyl transferase‐mediated dUTP–digoxigenin nick end‐labeling (TUNEL) method were used to detect apoptosis in gastric adenocarcinoma cell line SGC‐7901 before and after trichosanthin treatment. An immunohistochemical staining method and northern blot hybridization were used to detect the expression of the apoptosis‐related gene bcl‐2 before and after trichosanthin treatment. RESULTS: When SGC‐7901 cells were treated with trichosanthin (0.1 μg/mL, 36 h), they presented some typical apoptotic morphological changes that were observed by fluorescent staining. These morphological changes included nuclear condensation and nucleosomal fragments forming a lunate body under the nuclear membrane. When SGC‐7901 cells were treated with trichosanthin (0.1 μg/mL) for 36, 42 or 48 h, TUNEL staining revealed a significant increase in the apoptotic index (AI), from 3.78 ± 1.11%, 3.98 ± 1.12% and 3.85 ± 1.08%, to 11.30 ± 2.33%, 10.22 ± 2.00% and 11.18 ± 1.85% (P < 0.01), respectively. When SGC‐7901 cells were treated with trichosanthin (0.1 μg/mL, 32 h), immunohistochemical staining revealed a decreased expression of the bcl‐2 protein product: the staining density decreased from ++/+++ to –/+ (P < 0.01). When SGC‐7901 cells were treated with trichosanthin (0.1 μg/mL, 24 h), northern blot hybridization showed a decreased expression of bcl‐2 RNA: hybridization decreased from 35.19 ± 2.34 to 22.27 ± 3.90 (P < 0.01). CONCLUSIONS: Trichosanthin is able to induce apoptosis in gastric cancer. The apoptosis may be mediated by the downexpression of the apoptosis‐related gene bcl‐2.